Found 62 matching trials
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
EARLY_PHASE1The purpose of this study is to evaluate the efficacy and safety of allogen...
Location
Institute of Hematology & Blood Diseases Hospital
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT
PHASE1The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
N/AThe purpose of this study is to assess long-term side effects from subjects...
Status
Active Not Recruiting
Location
Blood and Marrow Transplant Program
Safety and Efficacy of γδ T Cell Against Gastric Cancer
PHASE1In this study, safety and effects of γδT cells on human gastric cancer are ...
Location
The First Affiliated Hospital of Guangzhou Medical University
A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19
PHASE2A Phase II safety and tolerability study of expanded gamma delta T cell lym...
Location
Royal Victoria Infirmary
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial
EARLY_PHASE1This study aims to evaluate the safety, tolerability and efficacy of ex-viv...
Location
Beijing 302 Hospital of China
Safety and Efficiency of γδ T Cell Against Lung Cancer
PHASE1In this study, effects of γδT cells on human Lung Cancer in combination wit...
Location
Biotherapy center in Fuda cancer hospital
Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)
PHASE1CAR-T is a pioneering cancer treatment which has found success in some canc...
Location
National University Hospital
Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia
PHASE1This study investigates the potential curative properties of ex-vivo expand...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
EARLY_PHASE1This study is a single-arm, single-center, open-label, dose-escalation expl...